AAVnerGene was excited to participate in the 2024 Society for Neuroscience (SfN) conference, one of the premier events in the neuroscience community. We were thrilled to see an overwhelming response at our booth, where we had the opportunity to engage with a diverse group of scientists, researchers, and industry professionals. Attendees showed keen interest in our advanced AAV (Adeno-Associated Virus) products, tailored services, and innovative technologies that drive the future of gene therapy.

We extend our sincere gratitude to everyone who took the time to meet with us, discuss the latest breakthroughs, and explore how our solutions can contribute to their research and clinical advancements. Your enthusiasm and feedback were invaluable, and we look forward to fostering meaningful partnerships that will help push the boundaries of gene therapy for neurological diseases.

Thank you for making this event such a successu2014we are excited about the opportunities ahead and can’t wait to collaborate on future innovations!